Please provide your email address to receive an email when new articles are posted on . The portable MRI detected a high percentage of stroke-related infarct. Hyperfine has “practical advantages” over ...

Christus Mother Frances Hospital in Tyler recently made a breakthrough on Jan. 16 by becoming the first in the United States to use the new portable magnetic resonance imaging (MRI) on their smallest ...

Data presented at the annual American Society of Neuroimaging meeting supports clinical value and broad utility of the portable Swoop(R) system in outpatient neurology. GUILFORD, Conn.--(BUSINESS WIRE ...

Atlantic Health Morristown Medical Center recently announced it is one of the first hospitals in the U.S. to use Hyperfine‘s next-generation AI-powered, portable magnetic resonance imaging system. The ...

Strong evidence supports the use of AI-powered portable MRI for stroke detection in multiple clinical settings, including the emergency department.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI ...

GUILFORD, Conn., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (HYPR), the groundbreaking medical device company that created the Swoop ® system, the world's first FDA-cleared portable MRI system, ...

Hyperfine, Inc. announced results from a large data set from an investigator-initiated study evaluating stroke detection with t ...

The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop® system is a promising tool for enabling critical stroke treatment choices in ...

JACKSONVILLE, Fla. (Ivanhoe Newswire) - Whether it’s the brain, spine, joints, tissues, or organs, 10 million people will get an MRI or magnetic resonance imaging. It’s a diagnostic imaging procedure ...

The largest dataset to date on stroke detection with the Swoop(R) system demonstrates the ability to identify small strokes rapidly and reliably, reinforcing its clinical value for acute care and ...

New dementia study actively enrolling and new data to be presented at the 2025 Alzheimer's Association International Conference. GUILFORD, Conn.--(BUSINESS WIRE)-- Hyperfine, Inc. (HYPR) (Nasdaq: HYPR ...